Panel Discussion: PROSTATE IMAGING
Baris Turkbey, MD, Steven P. Rowe, MD, PhD, and Sandeep Arora, MBBS, FSAR presented “Panel...
Read MoreSelect Page
Posted by Sandeep Arora, MBBS, FSAR | Aug 2024
Baris Turkbey, MD, Steven P. Rowe, MD, PhD, and Sandeep Arora, MBBS, FSAR presented “Panel...
Read MorePosted by Sandeep Arora, MBBS, FSAR | Aug 2024
Sandeep Arora, MBBS, FSAR, analyzes Prostate-Specific Membrane Antigen (PSMA) PET imaging in oncologic prostate care and ablative local therapy. His discourse emphasizes the critical role of PSMA PET in the accurate diagnosis, staging, and management of prostate cancer, while also addressing the potential limitations and challenges associated with this advanced imaging modality.
Dr. Arora outlines the key advantages of PSMA PET imaging, highlighting its superior sensitivity and specificity in detecting prostate cancer lesions compared to conventional imaging techniques. Dr. Arora also discusses the utility of PSMA PET in identifying biochemical recurrences and metastatic disease, allowing for timely and targeted therapeutic interventions.
Dr. Arora also delves into potential pitfalls of PSMA PET imaging, including false positives and false negatives, and ways of mitigating these issues. In addition, he examines the availability of PSMA PET tracers, the need for specialized equipment, and the expertise required for accurate image interpretation.
Read More